活动报名！医疗器械IPO招股书解读、上市前后传播合规实践

Core Viewpoint - The article emphasizes the importance of the IPO stage for medical device companies, highlighting that these companies often feel hesitant to communicate during this critical period [2]. Summary by Sections IPO Preparation and Communication - The article discusses the contents of the prospectus and the types of information that can be interpreted and utilized [3]. - It raises questions about the ability of companies to communicate externally before and after the IPO, and what roles the marketing and branding departments should play during this phase [3]. Event Information - An organized event for a small group of participants is scheduled for January 15, 2026, in Shanghai, focusing on IPO-related discussions [4]. - The event is hosted by organizations including Siyu MedTech and aims to facilitate dialogue among industry professionals [4]. Agenda and Participants - The agenda includes self-introductions, a presentation by a guest speaker, and open discussions [6]. - The target audience includes market/brand leaders from companies planning or undergoing IPOs, as well as management and strategic personnel [6]. Key Topics of Discussion - The guest speaker will cover three main areas: the readability of medical device prospectuses, compliance boundaries for corporate communication before and after the IPO, and actionable promotional strategies for companies [7]. - The article outlines the basic structure and key modules of a prospectus, detailing what different roles (marketing, investment, partners) typically focus on [8]. Compliance and Risk Management - It highlights the distinction between factual statements and those that may be misused, as well as what can be communicated versus what should be avoided [8]. - The article discusses common scenarios where promotional activities may cross compliance lines and the differences in risk before and after the IPO [8].